| Literature DB >> 35318403 |
Li-Shen Soh1, G Veera Singham2.
Abstract
The use of insecticides remains important in managing pest insects. Over the years, many insects manifested physiological and behavioral modifications resulting in reduced efficacy of insecticides targeted against them. Emerging evidence suggests that bacterial symbionts could modulate susceptibility of host insects against insecticides. Here, we explore the influence of host microbiota in affecting the susceptibility of insect host against different insecticides in the blood-sucking bed bug, Cimex hemipterus. Rifampicin antibiotic treatment resulted in increased susceptibility to fenitrothion and imidacloprid, but not against deltamethrin. Meanwhile, the host fitness parameters measured in the present study were not significantly affected by rifampicin treatment, suggesting the role of bacterial symbionts influencing susceptibility against the insecticides. 16S metagenomics sequencing revealed a drastic shift in the composition of several bacterial taxa following rifampicin treatment. The highly abundant Alphaproteobacteria (Wolbachia > 90%) and Gammaproteobacteria (Yersinia > 6%) in control bed bugs were significantly suppressed and replaced by Actinobacteria, Bacilli, and Betaproteobacteria in the rifampicin treated F1 bed bugs, suggesting possibilities of Wolbachia mediating insecticide susceptibility in C. hemipterus. However, no significant changes in the total esterase, GST, and P450 activities were observed following rifampicin treatment, indicating yet unknown bacterial mechanisms explaining the observed phenomena. Re-inoculation of microbial content from control individuals regained the tolerance of rifampicin treated bed bugs to imidacloprid and fenitrothion. This study provides a foundation for a symbiont-mediated mechanism in influencing insecticide susceptibility that was previously unknown to bed bugs.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35318403 PMCID: PMC8941108 DOI: 10.1038/s41598-022-09015-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Effects of antibiotic treatment on different life history traits of C. hemipterus. (a) fecundity; (b) hatching rate; (c) nymphal development. Asterisk denotes significant difference, P < 0.05 (independent t-test).
Restricted mean survival time (RMST) and knockdown response of C. hemipterus under 24 h continuous exposure and percentage mortality 48 h post-treatment against three different classes of insecticides.
| Insecticide | Treatment Group | Time Point (min) | RMST (95% CI) | KT100 (min) | Percentage mortality 48 h post-treatment (%) |
|---|---|---|---|---|---|
| Deltamethrin (192 mg/m2) | Control | 1440 | 1440.00 (1440.00–1440.00)a SE = 0.00 | > 1440.00a | 0.00a |
| F0 | 1440.00 (1440.00–1440.00)a SE = 0.00 | > 1440.00a | 0.00a | ||
| F1 | 1440.00 (1440.00–1440.00)a SE = 0.00 | > 1440.00a | 0.00a | ||
| Re-inoculated | 1440.00 (1440.00–1440.00)a SE = 0.00 | > 1440.00a | 0.00a | ||
| B vitamin | 1440.00 (1440.00–1440.00)a SE = 0.00 | > 1440.00a | 0.00a | ||
| Imidacloprid (192 mg/m2) | Control | 120 | 99.33 (91.83 -106.84)ab SE = 3.83 | 186.67 ± 13.33b | 66.67ab |
| F0 | 73.33 (53.50—83.17)c SE = 5.02 | 133.33 ± 6.67d | 76.33c | ||
| F1 | 63.33 (53.72—72.95)c SE = 4.91 | 113.33 ± 6.67d | 80.00c | ||
| Re-inoculated | 92.00 (82.84—101.17)b SE = 4.68 | 160.00 ± 0.00c | 73.33bc | ||
| B vitamin | 110.67 (104.07—117.26)a | 220.00 ± 0.00a | 63.33a | ||
| Fenitrothion (556 mg/m2) | Control | 600 | 514.00 (479.97—548.03)a SE = 17.36 | 940.00 ± 20.00a | 16.67a |
| F0 | 440.00 (404.79—475.21)b SE = 17.96 | 620.00 ± 52.92c | 43.33b | ||
| F1 | 390.00 (354.18—425.82)b SE = 18.28 | 560.00 ± 20.00c | 56.67b | ||
| Re-inoculated | 506.00 (472.88—539.12)a SE = 16.90 | 780.00 ± 34.61b | 23.33a | ||
| B vitamin | 532.00 (497.95—566.05)a | 1000 ± 20.00a | 20.00a |
Different letters in each row for each insecticide class indicate significant differences based on the comparison of restricted mean survival time (RMST) as determined by MedCalc software (P < 0.05) after Benjamini–Hochberg correction; Duncan’s multiple range test P < 0.05 for time to knockdown 100% bed bugs (KT100) and percentage mortality reported at 48 h post-treatment. Time point for RMST is pre-specified by Medcalc statistical software, set to the lowest time point of the last event among the different groups.
Figure 2Effect of rifampicin treatment on microbial composition of C. hemipterus based on the 16S rRNA metagenomics analysis. (a) Venn diagram showing the number of shared and unique OTUs among the study groups; (b) Rarefaction curves of all samples from the study groups. Each line represents each replicate used in the respective study groups; (c) Principal coordinate analysis (PCoA) showing bacteria dissimilarity between the individuals from different experimental groups (rifampicin treated F0:blue star and F1: brown diamond ; control: black triangle) based on Bray–Curtis distance metric. Each symbol denotes individual replicate used in the respective study groups; (d) Heatmap dendrogram illustrating abundance (%) of top 15 genera in each sample from the three experimental groups (control, F0 and F1) and clustered by averaged neighbor UPGMA method at threshold of 0.95.
Effect of antibiotic treatment on alpha diversity of microbial communities in C. hemipterus.
| Group | Fisher’s alpha | Shannon’s Index | Faith’s Phylogenetic Diversity | Pielou’s Evenness |
|---|---|---|---|---|
| Control | 4.11 ± 0.44a | 3.83 ± 0.01a | 2.08 ± 0.14a | 0.74 ± 0.02a |
| F0 | 3.96 ± 0.53a | 3.79 ± 0.02a | 2.14 ± 0.28a | 0.75 ± 0.02a |
| F1 | 8.68 ± 1.67b | 4.32 ± 0.07b | 3.32 ± 0.41b | 0.73 ± 0.03a |
Different letters in each column indicate significant differences based on Kruskal–Wallis test followed by Dunn’s Test and Benjamini–Hochberg correction (P < 0.05).
Mean relative abundance (%) ± SD of the predominant phyla, classes, orders, families, and genera found in C. hemipterus among the three study groups.
| Taxa | Corrected | Control | F0 | F1 |
|---|---|---|---|---|
| Proteobacteria | 1.49E−09 | 99.20 ± 0.31a | 99.20 ± 0.19a | 6.93 ± 2.52b |
| Actinobacteria | 1.76E−06 | 0.65 ± 0.41b | 0.65 ± 0.39b | 70.32 ± 6.26a |
| Firmicutes | 0.0049 | 0.13 ± 0.09b | 0.10 ± 0.13b | 22.39 ± 8.26a |
| Chlamydiae | 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.23 ± 0.32 |
| Bacteroidetes | 0.5600 | 0.00 ± 0.00 | 0.05 ± 0.07 | 0.12 ± 0.17 |
| Alphaproteobacteria | 1.37E−08 | 91.19 ± 2.86a | 92.75 ± 0.69a | 4.53 ± 1.90b |
| Gammaproteobacteria | 0.0218 | 8.01 ± 2.69a | 6.45 ± 0.78a | 1.78 ± 0.55b |
| Actinobacteria | 1.42E−06 | 0.65 ± 0.41b | 0.65 ± 0.39b | 70.13 ± 6.02a |
| Bacilli | 0.0056 | 0.13 ± 0.09b | 0.08 ± 0.10b | 22.25 ± 8.40a |
| Betaproteobacteria | 1.29E−05 | 0.00 ± 0.00b | 0.00 ± 0.01b | 0.62 ± 0.08a |
| Chlamydiia | 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.23 ± 0.32 |
| Coriobacteriia | 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.20 ± 0.28 |
| Clostridia | 0.4771 | 0.00 ± 0.00 | 0.02 ± 0.03 | 0.14 ± 0.20 |
| Bacteroidia | 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.12 ± 0.17 |
| Rickettsiales | 3.15E−09 | 91.09 ± 2.75a | 92.60 ± 0.72a | 0.42 ± 0.31b |
| Enterobacteriales | 0.0072 | 8.00 ± 2.69a | 6.39 ± 0.77a | 0.32 ± 0.14b |
| Actinomycetales | 1.42E−06 | 0.65 ± 0.41b | 0.65 ± 0.39b | 70.13 ± 6.02a |
| Unnamed Bacilli | 0.0049 | 0.11 ± 0.09b | 0.00 ± 0.00b | 21.23 ± 7.83a |
| Rhodobacterales | 2.43E−06 | 0.01 ± 0.02b | 0.00 ± 0.00b | 0.30 ± 0.02a |
| Pseudomonadales | 0.0003 | 0.01 ± 0.01b | 0.03 ± 0.04b | 1.11 ± 0.23a |
| Rhizobiales | 0.0304 | 0.03 ± 0.03 | 0.12 ± 0.15 | 3.07 ± 1.64 |
| Bacillales | 0.0885 | 0.01 ± 0.01 | 0.00 ± 0.01 | 0.88 ± 0.64 |
| Sphingomonadales | 0.4219 | 0.03 ± 0.04 | 0.03 ± 0.04 | 0.56 ± 0.37 |
| Burkholderiales | 0.0790 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.45 ± 0.32 |
| Chlamydiales | 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.23 ± 0.32 |
| Coriobacteriales | 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.20 ± 0.28 |
| Rickettsiaceae | 3.07E−09 | 91.08 ± 2.74a | 92.60 ± 0.71a | 0.42 ± 0.31b |
| Enterobacteriaceae | 0.0072 | 8.00 ± 2.69a | 6.39 ± 0.77a | 0.32 ± 0.14b |
| Brevibacteriaceae | 5.85E−05 | 0.50 ± 0.29b | 0.43 ± 0.25b | 43.78 ± 7.10a |
| Dietziaceae | 4.39E−05 | 0.13 ± 0.10b | 0.17 ± 0.12b | 24.54 ± 3.81a |
| Unnamed Bacilli | 0.0049 | 0.11 ± 0.09b | 0.00 ± 0.00b | 21.23 ± 7.83a |
| Pseudomonadaceae | 0.0108 | 0.00 ± 0.00b | 0.00 ± 0.00b | 0.45 ± 0.19a |
| Dermabacteraceae | 0.0018 | 0.00 ± 0.00b | 0.02 ± 002b | 0.39 ± 0.11a |
| Bradyrhizobiaceae | 0.0345 | 0.02 ± 0.02 | 0.04 ± 0.03 | 2.79 ± 1.56 |
| Moraxellaceae | 0.0552 | 0.01 ± 0.01 | 0.03 ± 0.04 | 0.66 ± 0.41 |
| Staphylococcaceae | 0.0781 | 0.01 ± 0.01 | 0.00 ± 0.00 | 0.44 ± 0.31 |
| Bacillaceae | 0.2023 | 0.00 ± 0.00 | 0.00 ± 0.01 | 0.44 ± 0.43 |
| Yaniellaceae | 0.1275 | 0.00 ± 0.00 | 0.02 ± 0.02 | 0.32 ± 0.26 |
| Oxalobacteraceae | 0.0849 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.24 ± 0.17 |
| Corynebacteriaceae | 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.23 ± 0.32 |
| Chlamydiaceae | 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.23 ± 0.32 |
| Micrococcaceae | 0.1263 | 0.01 ± 0.01 | 0.00 ± 0.00 | 0.23 ± 0.18 |
| Coriobacteriaceae | 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.20 ± 0.28 |
| 3.13E−09 | 91.09 ± 2.75a | 92.61 ± 0.71a | 0.42 ± 0.31b | |
| 0.0058 | 7.99 ± 2.69a | 6.36 ± 0.76a | 0.00 ± 0.00b | |
| 5.78E−05 | 0.50 ± 0.29b | 0.43 ± 0.25b | 43.77 ± 7.08a | |
| 4.57E−05 | 0.13 ± 0.10b | 0.17 ± 0.12b | 24.51 ± 3.83a | |
| Unnamed | 0.0049 | 0.11 ± 0.09b | 0.00 ± 0.00b | 21.23 ± 7.83a |
| 0.0023 | 0.01 ± 0.01b | 0.03 ± 0.04b | 0.46 ± 0.14a | |
| Unnamed | 9.15E−05 | 0.00 ± 0.00b | 0.02 ± 002b | 0.28 ± 0.04a |
| 0.0345 | 0.02 ± 0.02 | 0.04 ± 0.03 | 2.79 ± 1.56 | |
| 0.2024 | 0.00 ± 0.00 | 0.00 ± 0.01 | 0.44 ± 0.43 | |
| 0.0888 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.47 ± 0.20 | |
| 0.0638 | 0.01 ± 0.01 | 0.00 ± 0.00 | 0.36 ± 0.24 | |
| 0.0718 | 0.03 ± 0.04 | 0.03 ± 0.04 | 0.36 ± 0.22 | |
| 0.1275 | 0.00 ± 0.00 | 0.02 ± 0.02 | 0.32 ± 0.26 | |
| Unnamed | 0.4623 | 0.04 ± 0.05 | 0.00 ± 0.00 | 0.29 ± 0.42 |
| 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.23 ± 0.32 | |
| 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.23 ± 0.32 | |
| 0.4219 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.20 ± 0.28 | |
Different letters in the same row indicate statistical significance between taxonomic abundance based on STAMP analysis using ANOVA followed by Tukey–Kramer and Benjamini–Hochberg correction (P < 0.05).
Figure 3Functional prediction analysis generated by PICRUSt. (a) The relative abundance of the predicted functions grouped according to KEGG level 1 and 2 categories of the bacterial communities; (b) Extended error bar of predicted function subsystem of xenobiotics biodegradation and metabolism at KEGG level 3. The results were filtered using a Welch’s t-test (two groups comparison) with Benjamini–Hochberg FDR correction (P-value < 0.05) in STAMP v2.1.3.
Mean relative abundance of the predicted functions of the bacterial communities grouped according to KEGG pathway categories among the three study groups.
| Level 1 | Level 2 | Corrected | Control | F0 | F1 |
|---|---|---|---|---|---|
| Cellular Processes | Cell Growth and Death | 6.54E−07 | 1.21 ± 0.03a | 1.25 ± 0.02a | 0.51 ± 0.04b |
| Cell Motility | 0.8015 | 0.85 ± 0.09 | 0.76 ± 0.05 | 0.79 ± 0.22 | |
| Transport and Catabolism | 3.43E−06 | 0.26 ± 0.00b | 0.26 ± 0.00b | 0.41 ± 0.01a | |
| Environmental Information Processing | Membrane Transport | 0.0006 | 10.37 ± 0.30b | 10.08 ± 0.16b | 11.88 ± 0.24a |
| Signal Transduction | 2.94E−07 | 1.08 ± 0.07b | 1.01 ± 0.03b | 1.64 ± 0.02a | |
| Signaling Molecules and Interaction | 3.92E−06 | 0.01 ± 0.00b | 0.01 ± 0.00b | 0.17 ± 0.00a | |
| Genetic Information Processing | Folding, Sorting and Degradation | 1.65E−07 | 3.94 ± 0.06a | 3.98 ± 0.02a | 2.34 ± 0.08b |
| Replication and Repair | 8.44E−06 | 11.52 ± 0.19a | 11.69 ± 0.09a | 6.97 ± 0.30b | |
| Transcription | 0.0097 | 1.96 ± 0.02 | 1.94 ± 0.01 | 2.04 ± 0.05 | |
| Translation | 1.97E−08 | 9.22 ± 0.19a | 9.39 ± 0.09a | 4.43 ± 0.22 | |
| Human Diseases | Cancers | 1.02E−07 | 0.56 ± 0.02a | 0.58 ± 0.01a | 0.15 ± 0.02b |
| Cardiovascular Diseases | 3.35E−06 | 0.08 ± 0.00a | 0.08 ± 0.00a | 0.01 ± 0.01b | |
| Immune System Diseases | 5.65E−07 | 0.01 ± 0.00b | 0.01 ± 0.00 | 0.06 ± 0.00a | |
| Infectious Diseases | 2.15E−09 | 0.55 ± 0.00a | 0.55 ± 0.00a | 0.36 ± 0.01 | |
| Metabolic Diseases | 1.00E−07 | 0.09 ± 0.00b | 0.09 ± 0.00b | 0.11 ± 0.11a | |
| Neurodegenerative Diseases | 0.0006 | 1.19 ± 0.04a | 1.22 ± 0.02a | 0.25 ± 0.03b | |
| Metabolism | Amino Acid Metabolism | 5.69E−10 | 8.96 ± 0.04b | 9.00 ± 0.03b | 12.05 ± 0.06a |
| Biosynthesis of Other Secondary Metabolites | 5.28E−07 | 0.48 ± 0.01b | 0.48 ± 0.00b | 0.85 ± 0.03a | |
| Carbohydrate Metabolism | 1.09E−07 | 7.73 ± 0.08b | 7.66 ± 0.04b | 10.53 ± 0.14a | |
| Energy Metabolism | 7.83E−08 | 7.74 ± 0.10a | 7.83 ± 0.05a | 5.33 ± 0.07b | |
| Enzyme Families | 0.0021 | 1.70 ± 0.01b | 1.69 ± 0.01b | 1.85 ± 0.05a | |
| Glycan Biosynthesis and Metabolism | 0.0097 | 1.28 ± 0.03a | 1.24 ± 0.02a | 1.17 ± 0.01b | |
| Lipid Metabolism | 1.00E−07 | 2.67 ± 0.01b | 2.68 ± 0.00b | 4.27 ± 0.09a | |
| Metabolism of cofactors and vitamins | 0.0359 | 4.65 ± 0.02a | 4.67 ± 0.01a | 4.46 ± 0.11b | |
| Metabolism of other amino acids | 6.75E−07 | 1.33 ± 0.01b | 1.33 ± 0.00b | 2.33 ± 0.07a | |
| Metabolism of terpenoids and polyketides | 5.54E−07 | 1.91 ± 0.02b | 1.94 ± 0.01b | 2.62 ± 0.05a | |
| Nucleotide metabolism | 1.04E−06 | 5.51 ± 0.09a | 5.59 ± 0.04a | 3.57 ± 0.13b | |
| Xenobiotics biodegradation and metabolism | 1.42E−06 | 1.49 ± 0.03b | 1.49 ± 0.01b | 5.49 ± 0.38a | |
| Organismal Systems | Circulatory system | 1.75E−08 | 0.23 ± 0.01a | 0.24 ± 0.00a | 0.01 ± 0.00b |
| Digestive system | 6.41E−08 | 0.00 ± 0.00b | 0.00 ± 0.00b | 0.03 ± 0.00a | |
| Endocrine system | 2.42E−07 | 0.11 ± 0.01b | 0.11 ± 0.00b | 0.56 ± 0.03a | |
| Environmental adaptation | 4.17E−09 | 0.25 ± 0.00a | 0.26 ± 0.00a | 0.09 ± 0.00b | |
| Excretory system | 2.65E−10 | 0.00 ± 0.00b | 0.00 ± 0.00b | 0.08 ± 0.00a | |
| Immune system | 1.65E−07 | 0.16 ± 0.00a | 0.17 ± 0.00a | 0.05 ± 0.00b | |
| Nervous system | 8.44E−06 | 0.08 ± 0.00b | 0.08 ± 0.00b | 0.13 ± 0.00a | |
| Unclassified | Cellular processes and signaling | 0.0002 | 3.65 ± 0.05a | 3.50 ± 0.03a | 3.08 ± 0.07b |
| Genetic information processing | 8.44E−06 | 2.28 ± 0.00 | 2.28 ± 0.00 | 2.01 ± 0.03 | |
| Metabolism | 3.92E−06 | 1.71 ± 0.03b | 1.69 ± 0.01b | 2.60 ± 0.09a | |
| Poorly characterized | 0.0359 | 0.00 ± 0.00b | 3.16 ± 0.04b | 4.78 ± 0.11a |
Different letters in the same row indicate statistical significance between taxonomic abundance of predicted functions based on STAMP analysis using ANOVA followed by Tukey–Kramer and Benjamini–Hochberg correction (P < 0.05).